Ayala Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ayala Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $102K, a 93% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $102K -$1.36M -93% Dec 31, 2023 10-K 2024-04-16
Q3 2023 $1.28M +$1.26M +10533% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $1.39M +$1.37M +7216% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $65K +$39K +150% Mar 31, 2023 10-K 2024-04-16
Q4 2022 $1.46M -$288K -16.5% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $12K -$31K -72.1% Oct 31, 2022 10-K 2023-02-10
Q2 2022 $19K Jul 31, 2022 10-Q 2022-09-13
Q1 2022 $26K -$4.49M -99.4% Apr 30, 2022 10-Q 2022-06-08
Q4 2021 $1.75M -$2.89M -62.3% Jan 1, 2022 10-K 2024-04-16
Q3 2021 $43K -$4.8M -99.1% Sep 30, 2021 10-K 2023-02-10
Q1 2021 $4.51M -$706K -13.5% Mar 26, 2021 10-K 2023-02-10
Q4 2020 $4.64M -$758K -14% Jan 31, 2021 10-Q 2021-03-16
Q3 2020 $4.84M -$461K -8.7% Oct 31, 2020 10-K 2022-02-14
Q2 2020 $5.03M Jul 31, 2020 10-Q 2020-09-10
Q1 2020 $5.22M Apr 30, 2020 10-Q 2020-06-11
Q4 2019 $5.4M Jan 31, 2020 10-Q 2020-03-13
Q3 2019 $5.3M Oct 31, 2019 10-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.